Ind-Swift Laboratories Limited (ISLL) is raising funds upto Rs.500 crore either through GDR / FCCB / QIP to fund its expansion plans.
Its board of directors has decided to increase its authorized share capital from Rs.35 Cr to Rs.60 Cr.
Chandigarh-based Ind-Swift Laboratories, a part of the Ind-Swift group is involved in the manufacturing of APIs and advanced intermediates.